<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
GNPX
Genprex
$
()


  • Genprex collaborators report 'positive' data on Reqorsa, NPRL2 gene therapy

    4/9/2024 - 08:33am
  • Genprex expands clinical trial sites for study of Reqorsa in lung cancer

    4/3/2024 - 08:37am
  • Genprex initiated with bullish view at H.C. Wainwright, here's why

    3/25/2024 - 06:11am
  • Genprex announces $6.5M registered direct offering priced at the market

    3/19/2024 - 13:27pm
  • Genprex to sell 1.54M shares at $4.215 in registered direct offering priced ATM

    3/19/2024 - 08:56am
  • Genprex receives Notice of Patent Grant for Korean patent

    3/12/2024 - 09:02am
  • Biotech Alert: Searches spiking for these stocks today

    2/7/2024 - 11:01am
  • Genprex expands nonclinical programs to study TUSC2

    2/7/2024 - 08:19am
  • Genprex: First person dosed in Phase 2a expansion of Acclaim-1 trial

    2/5/2024 - 07:36am
  • Biotech Alert: Searches spiking for these stocks today

    2/2/2024 - 11:07am
  • Genprex trading halted, news pending

    2/1/2024 - 19:50pm
  • Biotech Alert: Searches spiking for these stocks today

    2/1/2024 - 11:24am
  • Genprex announces 1-for-40 reverse split

    1/31/2024 - 08:43am
  • Genprex receives ODD for Immunogene Therapy for treatment of SCLC

    9/21/2023 - 08:37am
  • Genprex granted FDA Orphan Drug Designation for Reqorsa in lung cancer

    8/10/2023 - 07:38am
dynamic_feed Breaking News